Authors
Latest:
The Societal Case for Pharmacist Provider StatusBeyond the benefits to the pharmacist profession, granting provider status to pharmacists addresses the larger societal problem of growing physician shortages.
Latest:
Asembia AXS25: Emotional Support Transforms Specialty Pharmacy Patient CareSpecialty pharmacy experts discuss how emotional support, addressing patient loneliness, and peer-to-patient programs can significantly improve medication adherence and patient care.
Latest:
Building a Future Workforce: Pharmacies Partner with High Schools to Sponsor Students Through Pharmacy Tech ProgramA projected shortage of trained staff in the years ahead demands looking beyond normal hiring channels.
Latest:
Wellness Support Group Shows Promise in Reducing BurnoutDiscussions are led by a variety of experienced preceptors to provide insight, strategies, and resources for pharmacy residents.
Latest:
Practice Pearl 3: Reducing Costs of PARPi for Ovarian Cancer TreatmentExperts in gynecologic oncology provide insight on available patient assistance programs to help lower costs of PARP inhibitors for the treatment of ovarian cancer, and how pharmacists can aid in obtaining this information.
Latest:
Pharmacists Play a Critical Role in Protecting Patients From Illegal Online Drug SellersAlthough approximately 95% of online drug sellers operate illegally, many consumers may never know the medications they receive are not what they claim to be.
Latest:
Counseling Patients About the Importance of Appropriate Pen Needle AdministrationAs use of injectable medications increases for diabetes and other indications, proper administration is crucial.
Latest:
ASCO 2025: Insights on NALIRIFOX Use in Metastatic Pancreatic Ductal Adenocarcinoma From the NAPOLI-3 TrialVincent Chung, MD, discusses key findings from the NAPOLI-3 trial and offers guidance for pharmacists on managing toxicities, adjusting dosing, and supporting patients receiving NALIRIFOX for metastatic pancreatic ductal adenocarcinoma.
Latest:
Headache or Harm: A Pharmacist’s Role in Differentiating Complement Inhibitor Adverse EffectsPharmacists play a crucial role in managing headaches in patients on complement inhibitors for PNH, ensuring proper education and risk mitigation strategies.
Latest:
Monkeypox Treatment and Prevention: Stopping the Latest OutbreakThere is not yet an FDA-approved treatment available for monkeypox, but existing antiviral agents have been found to be effective in vitro and in animal studies.
Latest:
Learn to Mitigate Feelings of Burnout and StressLack of acknowledgement or rewards in high-pressure pharmacy environments can lead to mental health issues.
Latest:
Educational Resources to Support PatientsPanelists discuss how comprehensive educational resources are essential for empowering patients with TD to better understand their condition, actively participate in their treatment decisions, and achieve optimal outcomes through improved self-management and adherence.
Latest:
Evaluation of Antibiotic Administration Surrounding Interventional Radiology ProceduresImplementation of a guidance document for periprocedural antibiotic prophylaxis resulted in improved appropriateness of antibiotic dose, selection, and duration for interventional radiology procedures.
Latest:
Changing the Game: Pharmacy Students' Perspective on Naloxone OTC ApprovalTo eliminate the existing stigma in the community, addiction must be recognized as a treatable condition rather than an immoral act.
Latest:
Assessing Prescriber Justification for Use of Outpatient Chemotherapy in the Acute Care SettingThis single-center, descriptive, retrospective chart review identified barriers to outpatient chemotherapy use, revealing avoidable inpatient stays and highlighting targets for stewardship interventions.
Latest:
This National Glaucoma Awareness Month, Pharmacists Can Have an Unparalleled Impact on Prevention, Treatment of GlaucomaPharmacists can play a key role in providing education and guidance to patients with glaucoma.
Latest:
New CMS Rules Underscore Pharmacists’ Role in Improving Glycemic ManagementThe measures will also affect workers across all areas of the hospital, including dietitians, information technology, nurses, and physicians.
Latest:
Topical Ketamine: A Promising New Avenue for PTSD TreatmentKetamine topical cream may alleviate symptoms of PTSD without causing the adverse effects and abuse potential often associated with other forms of ketamine administration.
Latest:
Empowering Diabetes Care: The Evolving Role of PharmacistsPharmacists are well-positioned to address diabetes from a multifaceted approach.
Latest:
Motivational Interviewing to Conquer Barriers for Diabetes ManagementMotivational interviewing serves as a beneficial strategy to enhance medication adherence and improve patient outcomes in diabetes management.
Latest:
Pain Management in the ICU Is ComplexFinding the right medication or drug combination for individual patients is critical.
Latest:
Proposed FDA Rule on Patient Medication Information Seeks to Address Prescription Misuse, NonadherenceImproved prescription information could help consumers make better health care decisions and result in cost savings.
Latest:
Mandatory Immunization of Health Care Workers Leads to ControversyLegal issues surfaced once again with the COVID-19 pandemic
Latest:
Gabapentin Presents High Potential for MisuseAlthough the anticonvulsant is not considered a controlled substance, some state legislation focuses on monitoring the use of or reclassifying it.
Latest:
Implementing USP <800> Guidelines in Pediatric HospitalsProtecting this vulnerable patient population requires specially designed strategies.
Latest:
Respect State Marijuana Laws Act of 2017 Amends Previous LegislationPast proposal gives insight into lawmakers' thinking about medicinal use of cannabis on a federal level.
Latest:
Considerations for RSV Prevention in Special Patient PopulationsOlder adults, patients with weakened immune systems, individuals living in long-term facilities, and those with underlying cardiopulmonary disease are at a higher risk of developing severe RSV infection outcomes.
Latest:
Brexanolone and Zuranolone for the Treatment of Postpartum DepressionThe American College of Clinical Gynecology recommends consideration of brexanolone or zuranolone in postpartum patients with onset of moderate-to-severe perinatal depression in the third trimester or within 4 weeks postpartum.
